Access the full text.
Sign up today, get DeepDyve free for 14 days.
(ZhanZSunLJinC Comparison between non-visualized polyps and visualized polyps on optical coherence tomography angiography in polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2019; 257:2349–2356.31446460)
ZhanZSunLJinC Comparison between non-visualized polyps and visualized polyps on optical coherence tomography angiography in polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2019; 257:2349–2356.31446460ZhanZSunLJinC Comparison between non-visualized polyps and visualized polyps on optical coherence tomography angiography in polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2019; 257:2349–2356.31446460, ZhanZSunLJinC Comparison between non-visualized polyps and visualized polyps on optical coherence tomography angiography in polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2019; 257:2349–2356.31446460
(DugelPUKohAOguraY HAWK and HARRIER: Phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology 2020; 127:72–84.30986442)
DugelPUKohAOguraY HAWK and HARRIER: Phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology 2020; 127:72–84.30986442DugelPUKohAOguraY HAWK and HARRIER: Phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology 2020; 127:72–84.30986442, DugelPUKohAOguraY HAWK and HARRIER: Phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology 2020; 127:72–84.30986442
(WooSJAhnJMorrisonMA Analysis of genetic and environmental risk factors and their interactions in Korean patients with age-related macular degeneration. PLoS One 2015; 10:e0132771.26171855)
WooSJAhnJMorrisonMA Analysis of genetic and environmental risk factors and their interactions in Korean patients with age-related macular degeneration. PLoS One 2015; 10:e0132771.26171855WooSJAhnJMorrisonMA Analysis of genetic and environmental risk factors and their interactions in Korean patients with age-related macular degeneration. PLoS One 2015; 10:e0132771.26171855, WooSJAhnJMorrisonMA Analysis of genetic and environmental risk factors and their interactions in Korean patients with age-related macular degeneration. PLoS One 2015; 10:e0132771.26171855
(FukuyamaHIwamiHArakiTIshikawaHIkedaNGomiF Indocyanine green dye filling time for polypoidal lesions in polypoidal choroidal vasculopathy affects the visibility of the lesions on OCT angiography. Ophthalmol Retina 2018; 2:803–807.31047533)
FukuyamaHIwamiHArakiTIshikawaHIkedaNGomiF Indocyanine green dye filling time for polypoidal lesions in polypoidal choroidal vasculopathy affects the visibility of the lesions on OCT angiography. Ophthalmol Retina 2018; 2:803–807.31047533FukuyamaHIwamiHArakiTIshikawaHIkedaNGomiF Indocyanine green dye filling time for polypoidal lesions in polypoidal choroidal vasculopathy affects the visibility of the lesions on OCT angiography. Ophthalmol Retina 2018; 2:803–807.31047533, FukuyamaHIwamiHArakiTIshikawaHIkedaNGomiF Indocyanine green dye filling time for polypoidal lesions in polypoidal choroidal vasculopathy affects the visibility of the lesions on OCT angiography. Ophthalmol Retina 2018; 2:803–807.31047533
R. Spaide, L. Yannuzzi, J. Slakter, J. Sorenson, Dennis Orlach (1995)
INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHYRetina, 15
(LaiTYChanWMLiuDTLukFOLamDS Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy. Br J Ophthalmol 2008; 92:661–666.18356265)
LaiTYChanWMLiuDTLukFOLamDS Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy. Br J Ophthalmol 2008; 92:661–666.18356265LaiTYChanWMLiuDTLukFOLamDS Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy. Br J Ophthalmol 2008; 92:661–666.18356265, LaiTYChanWMLiuDTLukFOLamDS Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy. Br J Ophthalmol 2008; 92:661–666.18356265
(LeeWKIidaTOguraY Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET Study: a randomized clinical trial. JAMA Ophthalmol 2018; 136:786–793.29801063)
LeeWKIidaTOguraY Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET Study: a randomized clinical trial. JAMA Ophthalmol 2018; 136:786–793.29801063LeeWKIidaTOguraY Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET Study: a randomized clinical trial. JAMA Ophthalmol 2018; 136:786–793.29801063, LeeWKIidaTOguraY Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET Study: a randomized clinical trial. JAMA Ophthalmol 2018; 136:786–793.29801063
(CoscasGLupidiMCoscasF Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration. Invest Ophthalmol Vis Sci 2015; 56:3187–3195.26024102)
CoscasGLupidiMCoscasF Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration. Invest Ophthalmol Vis Sci 2015; 56:3187–3195.26024102CoscasGLupidiMCoscasF Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration. Invest Ophthalmol Vis Sci 2015; 56:3187–3195.26024102, CoscasGLupidiMCoscasF Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration. Invest Ophthalmol Vis Sci 2015; 56:3187–3195.26024102
(2018)
Two different treat-and-extend dosing regimens of intravitreal aflibercept in Japanese patients with wet age-related macular degeneration: 96 week results of the ALTAIR study
C. Wong, Y. Yanagi, W. Lee, Y. Ogura, I. Yeo, T. Wong, C. Cheung (2016)
Age-related macular degeneration and polypoidal choroidal vasculopathy in AsiansProgress in Retinal and Eye Research, 53
(LeeWKBaekJDansinganiKKLeeJHFreundKB Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal choroidal thickness. Retina 2016; 36: suppl 1: S73–S82.28005665)
LeeWKBaekJDansinganiKKLeeJHFreundKB Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal choroidal thickness. Retina 2016; 36: suppl 1: S73–S82.28005665LeeWKBaekJDansinganiKKLeeJHFreundKB Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal choroidal thickness. Retina 2016; 36: suppl 1: S73–S82.28005665, LeeWKBaekJDansinganiKKLeeJHFreundKB Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal choroidal thickness. Retina 2016; 36: suppl 1: S73–S82.28005665
T. Ng, X. Liang, T. Lai, Li Ma, P. Tam, Jian Wang, L. Chen, H. Chen, C. Pang (2016)
HTRA1 promoter variant differentiates polypoidal choroidal vasculopathy from exudative age-related macular degenerationScientific Reports, 6
F. Gomi, Y. Oshima, R. Mori, M. Kano, M. Saito, Ayana Yamashita, E. Iwata, R. Maruko (2015)
INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY: The Fujisan StudyRetina, 35
J. Kim, O. Kwon, Hyun-Sub Oh, S. Kim, Y. You (2016)
Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathyGraefe's Archive for Clinical and Experimental Ophthalmology, 254
Q. Meng, Lvzhen Huang, Yaoyao Sun, Yu-jing Bai, Bin Wang, Wen-zhen Yu, Mingwei Zhao, Xiaoxin Li (2015)
Effect of High-Density Lipoprotein Metabolic Pathway Gene Variations and Risk Factors on Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in ChinaPLoS ONE, 10
(SternRMZakovZNZegarraHGutmanFA Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women. Am J Ophthalmol 1985; 100:560–569.2413762)
SternRMZakovZNZegarraHGutmanFA Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women. Am J Ophthalmol 1985; 100:560–569.2413762SternRMZakovZNZegarraHGutmanFA Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women. Am J Ophthalmol 1985; 100:560–569.2413762, SternRMZakovZNZegarraHGutmanFA Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women. Am J Ophthalmol 1985; 100:560–569.2413762
Saeed Alshahrani, H. Shamsi, E. Kahtani, N. Ghazi (2014)
Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth patternClinical Ophthalmology (Auckland, N.Z.), 8
Thomas Hong, A. Tan, P. Mitchell, Jie-Jin Wang (2011)
A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration.Survey of ophthalmology, 56 3
(KimJYKwonOWOhHSKimSHYouYS Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2016; 254:1505–1510.26617178)
KimJYKwonOWOhHSKimSHYouYS Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2016; 254:1505–1510.26617178KimJYKwonOWOhHSKimSHYouYS Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2016; 254:1505–1510.26617178, KimJYKwonOWOhHSKimSHYouYS Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2016; 254:1505–1510.26617178
A. Tan, Y. Yanagi, G. Cheung (2019)
COMPARISON OF MULTICOLOR IMAGING AND COLOR FUNDUS PHOTOGRAPHY IN THE DETECTION OF PATHOLOGICAL FINDINGS IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY.Retina
Qiyu Bo, Quan Yan, Mengxi Shen, Minlu Song, Mengsha Sun, Yang Yu, P. Rosenfeld, Fenghua Wang, Xiaodong Sun (2019)
Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography.JAMA ophthalmology
R. Rosa, Janet Davis, C. Eifrig (2002)
Clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathyArchives of Ophthalmology, 120
(CheungCMLaiTYChenSJ Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: the group experience with digital fundus photography and confocal scanning laser ophthalmoscopy. Retina 2014; 34:2397–2406.25072645)
CheungCMLaiTYChenSJ Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: the group experience with digital fundus photography and confocal scanning laser ophthalmoscopy. Retina 2014; 34:2397–2406.25072645CheungCMLaiTYChenSJ Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: the group experience with digital fundus photography and confocal scanning laser ophthalmoscopy. Retina 2014; 34:2397–2406.25072645, CheungCMLaiTYChenSJ Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: the group experience with digital fundus photography and confocal scanning laser ophthalmoscopy. Retina 2014; 34:2397–2406.25072645
(TanCS The Role of optical coherence tomography angiography in polypoidal choroidal vasculopathy. JAMA Ophthalmol 2017; 135:1316–1317.29049455)
TanCS The Role of optical coherence tomography angiography in polypoidal choroidal vasculopathy. JAMA Ophthalmol 2017; 135:1316–1317.29049455TanCS The Role of optical coherence tomography angiography in polypoidal choroidal vasculopathy. JAMA Ophthalmol 2017; 135:1316–1317.29049455, TanCS The Role of optical coherence tomography angiography in polypoidal choroidal vasculopathy. JAMA Ophthalmol 2017; 135:1316–1317.29049455
(CoscasGYamashiroKCoscasF Comparison of exudative age-related macular degeneration subtypes in Japanese and French Patients: multicenter diagnosis with multimodal imaging. Am J Ophthalmol 2014; 158:e302.)
CoscasGYamashiroKCoscasF Comparison of exudative age-related macular degeneration subtypes in Japanese and French Patients: multicenter diagnosis with multimodal imaging. Am J Ophthalmol 2014; 158:e302.CoscasGYamashiroKCoscasF Comparison of exudative age-related macular degeneration subtypes in Japanese and French Patients: multicenter diagnosis with multimodal imaging. Am J Ophthalmol 2014; 158:e302., CoscasGYamashiroKCoscasF Comparison of exudative age-related macular degeneration subtypes in Japanese and French Patients: multicenter diagnosis with multimodal imaging. Am J Ophthalmol 2014; 158:e302.
(HuangLZhangHChengCY A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy. Nat Genet 2016; 48:640–647.27089177)
HuangLZhangHChengCY A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy. Nat Genet 2016; 48:640–647.27089177HuangLZhangHChengCY A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy. Nat Genet 2016; 48:640–647.27089177, HuangLZhangHChengCY A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy. Nat Genet 2016; 48:640–647.27089177
M. Kikuchi, Makoto Nakamura, K. Ishikawa, Toshimitsu Suzuki, H. Nishihara, T. Yamakoshi, K. Nishio, Kentaro Taki, T. Niwa, N. Hamajima, H. Terasaki (2007)
Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.Ophthalmology, 114 9
(SakuradaYYoneyamaSImasawaMIijimaH Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Retina 2013; 33:841–845.23400077)
SakuradaYYoneyamaSImasawaMIijimaH Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Retina 2013; 33:841–845.23400077SakuradaYYoneyamaSImasawaMIijimaH Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Retina 2013; 33:841–845.23400077, SakuradaYYoneyamaSImasawaMIijimaH Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Retina 2013; 33:841–845.23400077
Yoichi Sakurada, Seigo Yoneyama, M. Imasawa, H. Iijima (2013)
SYSTEMIC RISK FACTORS ASSOCIATED WITH POLYPOIDAL CHOROIDAL VASCULOPATHY AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina, 33
(TanCSNgoWKChenJPTanNWLimTH EVEREST Study GroupEVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol 2015; 99:624–628.25758601)
TanCSNgoWKChenJPTanNWLimTH EVEREST Study GroupEVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol 2015; 99:624–628.25758601TanCSNgoWKChenJPTanNWLimTH EVEREST Study GroupEVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol 2015; 99:624–628.25758601, TanCSNgoWKChenJPTanNWLimTH EVEREST Study GroupEVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol 2015; 99:624–628.25758601
F. Gomi, M. Sawa, H. Sakaguchi, M. Tsujikawa, Y. Oshima, M. Kamei, Y. Tano (2007)
Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathyBritish Journal of Ophthalmology, 92
Yo-Chen Chang, Wen-Chuan Wu (2009)
Polypoidal choroidal vasculopathy in Taiwanese patients.Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye, 40 6
(CiardellaAPDonsoffIMYannuzziLA Polypoidal choroidal vasculopathy. Ophthalmol Clin North Am 2002; 15:537–554.12515086)
CiardellaAPDonsoffIMYannuzziLA Polypoidal choroidal vasculopathy. Ophthalmol Clin North Am 2002; 15:537–554.12515086CiardellaAPDonsoffIMYannuzziLA Polypoidal choroidal vasculopathy. Ophthalmol Clin North Am 2002; 15:537–554.12515086, CiardellaAPDonsoffIMYannuzziLA Polypoidal choroidal vasculopathy. Ophthalmol Clin North Am 2002; 15:537–554.12515086
(LiuRLiJLiZ Distingishing polypoidal choroidal vasculopathy from typical neovascular age-related macular degeneration based on spectral domain optical coherence tomography. Retina 2016; 36:778–786.26428604)
LiuRLiJLiZ Distingishing polypoidal choroidal vasculopathy from typical neovascular age-related macular degeneration based on spectral domain optical coherence tomography. Retina 2016; 36:778–786.26428604LiuRLiJLiZ Distingishing polypoidal choroidal vasculopathy from typical neovascular age-related macular degeneration based on spectral domain optical coherence tomography. Retina 2016; 36:778–786.26428604, LiuRLiJLiZ Distingishing polypoidal choroidal vasculopathy from typical neovascular age-related macular degeneration based on spectral domain optical coherence tomography. Retina 2016; 36:778–786.26428604
ID Ladas, AA Rouvas, MM Moschos, EE Synodinos, DA Karagiannis, CN Koutsandrea (2004)
Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek populationEye, 18
(Japanese Study Group of Polypoidal Choroidal Vasculopathy[Criteria for diagnosis of polypoidal choroidal vasculopathy]. Nippon Ganka Gakkai Zasshi 2005; 109:417–427.16050460)
Japanese Study Group of Polypoidal Choroidal Vasculopathy[Criteria for diagnosis of polypoidal choroidal vasculopathy]. Nippon Ganka Gakkai Zasshi 2005; 109:417–427.16050460Japanese Study Group of Polypoidal Choroidal Vasculopathy[Criteria for diagnosis of polypoidal choroidal vasculopathy]. Nippon Ganka Gakkai Zasshi 2005; 109:417–427.16050460, Japanese Study Group of Polypoidal Choroidal Vasculopathy[Criteria for diagnosis of polypoidal choroidal vasculopathy]. Nippon Ganka Gakkai Zasshi 2005; 109:417–427.16050460
Lulin Huang, Houbin Zhang, Ching-Yu Cheng, F. Wen, P. Tam, Peiquan Zhao, H. Chen, Zheng Li, Li-Jia Chen, Zhengfu Tai, K. Yamashiro, Shaoping Deng, Xianjun Zhu, Weiqi Chen, L. Cai, Fang Lu, Yuanfeng Li, C. Cheung, Yi Shi, M. Miyake, Yin Lin, B. Gong, Xiaoqi Liu, K. Sim, Jiyun Yang, Keisuke Mori, Xiongzhe Zhang, P. Cackett, M. Tsujikawa, K. Nishida, F. Hao, Shi Ma, He Lin, Jing Cheng, P. Fei, T. Lai, S. Tang, A. Laude, Satoshi Inoue, I. Yeo, Yoichi Sakurada, Yu Zhou, H. Iijima, S. Honda, Chun-tao Lei, Lin Zhang, Hong Zheng, Dan Jiang, Xiong Zhu, T. Wong, C. Khor, C. Pang, N. Yoshimura, Zhenglin Yang (2016)
A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathyNature Genetics, 48
Pachychoroid Neovasculopathy, C. Pang (2015)
PACHYCHOROID NEOVASCULOPATHYRetina, 35
(KikuchiMNakamuraMIshikawaK Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmology 2007; 114:1722–1727.17400294)
KikuchiMNakamuraMIshikawaK Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmology 2007; 114:1722–1727.17400294KikuchiMNakamuraMIshikawaK Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmology 2007; 114:1722–1727.17400294, KikuchiMNakamuraMIshikawaK Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmology 2007; 114:1722–1727.17400294
(TanACSYanagiYCheungGCM Comparison of multicolor imaging and color fundus photography in the detection of pathological findings in eyes with polypoidal choroidal vasculopathy. Retina 2019; [Epub ahead of print].)
TanACSYanagiYCheungGCM Comparison of multicolor imaging and color fundus photography in the detection of pathological findings in eyes with polypoidal choroidal vasculopathy. Retina 2019; [Epub ahead of print].TanACSYanagiYCheungGCM Comparison of multicolor imaging and color fundus photography in the detection of pathological findings in eyes with polypoidal choroidal vasculopathy. Retina 2019; [Epub ahead of print]., TanACSYanagiYCheungGCM Comparison of multicolor imaging and color fundus photography in the detection of pathological findings in eyes with polypoidal choroidal vasculopathy. Retina 2019; [Epub ahead of print].
(FujiwaraKYasudaMHataJ Prevalence and risk factors for polypoidal choroidal vasculopathy in a general japanese population: The Hisayama Study. Semin Ophthalmol 2018; 33:813–819.30084710)
FujiwaraKYasudaMHataJ Prevalence and risk factors for polypoidal choroidal vasculopathy in a general japanese population: The Hisayama Study. Semin Ophthalmol 2018; 33:813–819.30084710FujiwaraKYasudaMHataJ Prevalence and risk factors for polypoidal choroidal vasculopathy in a general japanese population: The Hisayama Study. Semin Ophthalmol 2018; 33:813–819.30084710, FujiwaraKYasudaMHataJ Prevalence and risk factors for polypoidal choroidal vasculopathy in a general japanese population: The Hisayama Study. Semin Ophthalmol 2018; 33:813–819.30084710
A. Tsujikawa, Yumiko Ojima, K. Yamashiro, Isao Nakata, S. Ooto, H. Tamura, Hideo Nakanishi, Hisako Hayashi, A. Otani, N. Yoshimura (2011)
Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy.American journal of ophthalmology, 151 6
Gabriella Salvo, Sara Vaz-Pereira, P. Keane, A. Tufail, Gerald Liew (2014)
Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy.American journal of ophthalmology, 158 6
T. Ueta, Ryo Obata, Yuji Inoue, A. Iriyama, Hidenori Takahashi, Takuhiro Yamaguchi, Y. Tamaki, Y. Yanagi (2009)
Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.Ophthalmology, 116 12
(NgTKLiangXYLaiTY HTRA1 promoter variant differentiates polypoidal choroidal vasculopathy from exudative age-related macular degeneration. Sci Rep 2016; 6:28639.27338780)
NgTKLiangXYLaiTY HTRA1 promoter variant differentiates polypoidal choroidal vasculopathy from exudative age-related macular degeneration. Sci Rep 2016; 6:28639.27338780NgTKLiangXYLaiTY HTRA1 promoter variant differentiates polypoidal choroidal vasculopathy from exudative age-related macular degeneration. Sci Rep 2016; 6:28639.27338780, NgTKLiangXYLaiTY HTRA1 promoter variant differentiates polypoidal choroidal vasculopathy from exudative age-related macular degeneration. Sci Rep 2016; 6:28639.27338780
S. Honda, Wataru Matsumiya, A. Negi (2013)
Polypoidal Choroidal Vasculopathy: Clinical Features and Genetic PredispositionOphthalmologica, 231
(SakuradaYKubotaTImasawaM Role of complement factor H I62 V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy. Ophthalmology 2011; 118:1402–1407.21397333)
SakuradaYKubotaTImasawaM Role of complement factor H I62 V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy. Ophthalmology 2011; 118:1402–1407.21397333SakuradaYKubotaTImasawaM Role of complement factor H I62 V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy. Ophthalmology 2011; 118:1402–1407.21397333, SakuradaYKubotaTImasawaM Role of complement factor H I62 V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy. Ophthalmology 2011; 118:1402–1407.21397333
S. Byeon, S. Lee, Hyun-Sub Oh, S. Kim, H. Koh, O. Kwon (2008)
Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patientsJapanese Journal of Ophthalmology, 52
Koji Tanaka, T. Nakayama, R. Mori, N. Sato, A. Kawamura, Y. Mizutani, M. Yuzawa (2011)
Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy.Investigative ophthalmology & visual science, 52 10
(RosaRHJrDavisJLEifrigCW Clinicopathologic reports, case reports, and small case series: clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 2002; 120:502–508.11934327)
RosaRHJrDavisJLEifrigCW Clinicopathologic reports, case reports, and small case series: clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 2002; 120:502–508.11934327RosaRHJrDavisJLEifrigCW Clinicopathologic reports, case reports, and small case series: clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 2002; 120:502–508.11934327, RosaRHJrDavisJLEifrigCW Clinicopathologic reports, case reports, and small case series: clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 2002; 120:502–508.11934327
John Thomas, H. Grossniklaus, H. Lambert, T. Aaberg (1993)
ULTRASTRUCTURAL FEATURES OF SURGICALLY EXCISED IDIOPATHIC SUBFOVEAL NEOVASCULAR MEMBRANESRetina, 13
(LafautBAAisenbreySVan den BroeckeCBartz-SchmidtKUHeimannK Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 2000; 20:650–654.11131419)
LafautBAAisenbreySVan den BroeckeCBartz-SchmidtKUHeimannK Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 2000; 20:650–654.11131419LafautBAAisenbreySVan den BroeckeCBartz-SchmidtKUHeimannK Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 2000; 20:650–654.11131419, LafautBAAisenbreySVan den BroeckeCBartz-SchmidtKUHeimannK Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 2000; 20:650–654.11131419
Yoichi Sakurada, T. Kubota, M. Imasawa, T. Tsumura, F. Mabuchi, H. Iijima (2009)
ANGIOGRAPHIC LESION SIZE ASSOCIATED WITH LOC387715 A69S GENOTYPE IN SUBFOVEAL POLYPOIDAL CHOROIDAL VASCULOPATHYRetina, 29
(TanCSTingDSLimLW Multicolor fundus imaging of polypoidal choroidal vasculopathy. Ophthalmol Retina 2019; 3:400–409.31044730)
TanCSTingDSLimLW Multicolor fundus imaging of polypoidal choroidal vasculopathy. Ophthalmol Retina 2019; 3:400–409.31044730TanCSTingDSLimLW Multicolor fundus imaging of polypoidal choroidal vasculopathy. Ophthalmol Retina 2019; 3:400–409.31044730, TanCSTingDSLimLW Multicolor fundus imaging of polypoidal choroidal vasculopathy. Ophthalmol Retina 2019; 3:400–409.31044730
C. Cheung, T. Lai, Shih-Jen Chen, V. Chong, W. Lee, H. Htoon, Wei Ng, Y. Ogura, T. Wong (2014)
UNDERSTANDING INDOCYANINE GREEN ANGIOGRAPHY IN POLYPOIDAL CHOROIDAL VASCULOPATHY: The Group Experience With Digital Fundus Photography and Confocal Scanning Laser OphthalmoscopyRetina, 34
(SpaideRFYannuzziLASlakterJSSorensonJOrlachDA Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995; 15:100–110.7542796)
SpaideRFYannuzziLASlakterJSSorensonJOrlachDA Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995; 15:100–110.7542796SpaideRFYannuzziLASlakterJSSorensonJOrlachDA Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995; 15:100–110.7542796, SpaideRFYannuzziLASlakterJSSorensonJOrlachDA Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995; 15:100–110.7542796
Colin Tan, W. Ngo, L. Lim, T. Lim (2014)
A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomesBritish Journal of Ophthalmology, 98
(NakashizukaHMitsumataMOkisakaS Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2008; 49:4729–4737.18586873)
NakashizukaHMitsumataMOkisakaS Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2008; 49:4729–4737.18586873NakashizukaHMitsumataMOkisakaS Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2008; 49:4729–4737.18586873, NakashizukaHMitsumataMOkisakaS Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2008; 49:4729–4737.18586873
Xiongze Zhang, F. Wen, C. Zuo, Meng Li, Hui Chen, Kun-fang Wu (2011)
Association of genetic variation on chromosome 9p21 with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.Investigative ophthalmology & visual science, 52 11
Maiko Inoue, Chandrakumar Balaratnasingam, K. Freund (2015)
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF POLYPOIDAL CHOROIDAL VASCULOPATHY AND POLYPOIDAL CHOROIDAL NEOVASCULARIZATIONRetina, 35
J. Qu, Yong Cheng, Xiaoxin Li, Liyun Yu, X. Ke (2016)
EFFICACY OF INTRAVITREAL INJECTION OF CONBERCEPT IN POLYPOIDAL CHOROIDAL VASCULOPATHY: Subgroup Analysis of the Aurora StudyRetina, 36
Colin Tan, W. Ngo, Jian Chen, Nikolle Tan, T. Lim (2015)
EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathyThe British Journal of Ophthalmology, 99
(Jaffe G. Sub-group analysis of Japanese polypoidal choroidal vasculopathy patients in the HAWK study. Presented at Americal Academy of Ophthalmology 2019 Annual Meeting Retina Subspecialty Day.)
Jaffe G. Sub-group analysis of Japanese polypoidal choroidal vasculopathy patients in the HAWK study. Presented at Americal Academy of Ophthalmology 2019 Annual Meeting Retina Subspecialty Day.Jaffe G. Sub-group analysis of Japanese polypoidal choroidal vasculopathy patients in the HAWK study. Presented at Americal Academy of Ophthalmology 2019 Annual Meeting Retina Subspecialty Day., Jaffe G. Sub-group analysis of Japanese polypoidal choroidal vasculopathy patients in the HAWK study. Presented at Americal Academy of Ophthalmology 2019 Annual Meeting Retina Subspecialty Day.
R. Rosa, Janet Davis, C. Eifrig (2002)
Clinicopathologic reports, case reports, and small case series: clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy.Archives of ophthalmology, 120 4
Daniel Pauleikhoff, D. Loffert, Georg Spital, Martin Radermacher, J. Dohrmann, Albrecht Lommatzsch, A. Bird (2002)
Pigment epithelial detachment in the elderlyGraefe's Archive for Clinical and Experimental Ophthalmology, 240
Chui Cheung, I. Yeo, Xiang Li, R. Mathur, Shu-Yen Lee, C. Chan, Doric Wong, T. Wong (2013)
Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy.American journal of ophthalmology, 155 2
(CheungCMLiXChengCY Prevalence, racial variations, and risk factors of age-related macular degeneration in Singaporean Chinese, Indians, and Malays. Ophthalmology 2014; 121:1598–1603.24661862)
CheungCMLiXChengCY Prevalence, racial variations, and risk factors of age-related macular degeneration in Singaporean Chinese, Indians, and Malays. Ophthalmology 2014; 121:1598–1603.24661862CheungCMLiXChengCY Prevalence, racial variations, and risk factors of age-related macular degeneration in Singaporean Chinese, Indians, and Malays. Ophthalmology 2014; 121:1598–1603.24661862, CheungCMLiXChengCY Prevalence, racial variations, and risk factors of age-related macular degeneration in Singaporean Chinese, Indians, and Malays. Ophthalmology 2014; 121:1598–1603.24661862
(SinghSRGoyalPParameswarappaDCGoudAChhablaniJ Angiographic features of polypoidal choroidal vasculopathy using indocyanine green angiography and optical coherence tomography angiography: a comparative study. Eur J Ophthalmol 2019; 22:1120672119850075.)
SinghSRGoyalPParameswarappaDCGoudAChhablaniJ Angiographic features of polypoidal choroidal vasculopathy using indocyanine green angiography and optical coherence tomography angiography: a comparative study. Eur J Ophthalmol 2019; 22:1120672119850075.SinghSRGoyalPParameswarappaDCGoudAChhablaniJ Angiographic features of polypoidal choroidal vasculopathy using indocyanine green angiography and optical coherence tomography angiography: a comparative study. Eur J Ophthalmol 2019; 22:1120672119850075., SinghSRGoyalPParameswarappaDCGoudAChhablaniJ Angiographic features of polypoidal choroidal vasculopathy using indocyanine green angiography and optical coherence tomography angiography: a comparative study. Eur J Ophthalmol 2019; 22:1120672119850075.
Xiongze Zhang, Meng Li, F. Wen, C. Zuo, Hui Chen, Kun-fang Wu, Renpan Zeng (2013)
Different impact of high-density lipoprotein-related genetic variants on polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population.Experimental eye research, 108
(KleinerRCBruckerAJJohnstonRL The posterior uveal bleeding syndrome. Retina 1990; 10:9–17.2343198)
KleinerRCBruckerAJJohnstonRL The posterior uveal bleeding syndrome. Retina 1990; 10:9–17.2343198KleinerRCBruckerAJJohnstonRL The posterior uveal bleeding syndrome. Retina 1990; 10:9–17.2343198, KleinerRCBruckerAJJohnstonRL The posterior uveal bleeding syndrome. Retina 1990; 10:9–17.2343198
(Gemmy CheungCMYeoILiX Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy. Am J Ophthalmol 2013; 155:295–304.23111181)
Gemmy CheungCMYeoILiX Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy. Am J Ophthalmol 2013; 155:295–304.23111181Gemmy CheungCMYeoILiX Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy. Am J Ophthalmol 2013; 155:295–304.23111181, Gemmy CheungCMYeoILiX Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy. Am J Ophthalmol 2013; 155:295–304.23111181
(LiangXYChenLJNgTK FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Eye (Lond) 2014; 28:1502–1510.25277308)
LiangXYChenLJNgTK FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Eye (Lond) 2014; 28:1502–1510.25277308LiangXYChenLJNgTK FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Eye (Lond) 2014; 28:1502–1510.25277308, LiangXYChenLJNgTK FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Eye (Lond) 2014; 28:1502–1510.25277308
A. Koh, Lee‐Jen Chen, Shih-Jen Chen, You-xin Chen, A. Giridhar, T. Iida, Hakyoung Kim, T. Lai, W. Lee, Xiaoxin Li, Tock Lim, Paisan Ruamviboonsuk, T. Sharma, Shibo Tang, M. Yuzawa (2013)
POLYPOIDAL CHOROIDAL VASCULOPATHY: Evidence-Based Guidelines for Clinical Diagnosis and TreatmentRetina, 33
(KohAHChenLJChenSJ Expert PCV PanelPolypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina 2013; 33:686–716.23455233)
KohAHChenLJChenSJ Expert PCV PanelPolypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina 2013; 33:686–716.23455233KohAHChenLJChenSJ Expert PCV PanelPolypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina 2013; 33:686–716.23455233, KohAHChenLJChenSJ Expert PCV PanelPolypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina 2013; 33:686–716.23455233
R. Kleiner, A. Brucker, R. Johnston (1990)
THE POSTERIOR UVEAL BLEEDING SYNDROMERetina, 10
(ByeonSHLeeSCOhHSKimSSKohHJKwonOW Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients. Jpn J Ophthalmol 2008; 52:57–62.18369702)
ByeonSHLeeSCOhHSKimSSKohHJKwonOW Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients. Jpn J Ophthalmol 2008; 52:57–62.18369702ByeonSHLeeSCOhHSKimSSKohHJKwonOW Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients. Jpn J Ophthalmol 2008; 52:57–62.18369702, ByeonSHLeeSCOhHSKimSSKohHJKwonOW Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients. Jpn J Ophthalmol 2008; 52:57–62.18369702
A. Laude, P. Cackett, E. Vithana, I. Yeo, Doric Wong, A. Koh, T. Wong, T. Aung (2010)
Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease?Progress in Retinal and Eye Research, 29
S. Woo, Jeeyun Ahn, M. Morrison, SohYeon Ahn, Jaebong Lee, Ki Kim, M. DeAngelis, K. Park (2015)
Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular DegenerationPLoS ONE, 10
Li Ma, M. Brelen, M. Tsujikawa, H. Chen, W. Chu, T. Lai, Danny Ng, K. Sayanagi, C. Hara, N. Hashida, V. Chan, P. Tam, A. Young, Weiqi Chen, K. Nishida, C. Pang, L. Chen (2017)
Identification of ANGPT2 as a New Gene for Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in the Chinese and Japanese Populations.Investigative ophthalmology & visual science, 58 2
S. Singh, P. Goyal, D. Parameswarappa, Abhilash Goud, J. Chhablani (2020)
Angiographic features of polypoidal choroidal vasculopathy using indocyanine green angiography and optical coherence tomography angiography: A comparative studyEuropean Journal of Ophthalmology, 30
(HondaSMatsumiyaWNegiA Polypoidal choroidal vasculopathy: clinical features and genetic predisposition. Ophthalmologica 2014; 231:59–74.24280967)
HondaSMatsumiyaWNegiA Polypoidal choroidal vasculopathy: clinical features and genetic predisposition. Ophthalmologica 2014; 231:59–74.24280967HondaSMatsumiyaWNegiA Polypoidal choroidal vasculopathy: clinical features and genetic predisposition. Ophthalmologica 2014; 231:59–74.24280967, HondaSMatsumiyaWNegiA Polypoidal choroidal vasculopathy: clinical features and genetic predisposition. Ophthalmologica 2014; 231:59–74.24280967
(YannuzziLASorensonJSpaideRFLipsonB Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990; 10:1–8.1693009)
YannuzziLASorensonJSpaideRFLipsonB Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990; 10:1–8.1693009YannuzziLASorensonJSpaideRFLipsonB Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990; 10:1–8.1693009, YannuzziLASorensonJSpaideRFLipsonB Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990; 10:1–8.1693009
(KohALeeWKChenLJ EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 2012; 32:1453–1464.22426346)
KohALeeWKChenLJ EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 2012; 32:1453–1464.22426346KohALeeWKChenLJ EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 2012; 32:1453–1464.22426346, KohALeeWKChenLJ EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 2012; 32:1453–1464.22426346
B. Lafaut, A. Leys, B. Snyers, F. Rasquin, J. Laey (2000)
Polypoidal choroidal vasculopathy in CaucasiansGraefe's Archive for Clinical and Experimental Ophthalmology, 238
(GomiFSawaMSakaguchiH Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol 2008; 92:70–73.17567661)
GomiFSawaMSakaguchiH Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol 2008; 92:70–73.17567661GomiFSawaMSakaguchiH Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol 2008; 92:70–73.17567661, GomiFSawaMSakaguchiH Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol 2008; 92:70–73.17567661
(LafautBALeysAMSnyersBRasquinFDe LaeyJJ Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch Clin Exp Ophthalmol 2000; 238:752–759.11045343)
LafautBALeysAMSnyersBRasquinFDe LaeyJJ Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch Clin Exp Ophthalmol 2000; 238:752–759.11045343LafautBALeysAMSnyersBRasquinFDe LaeyJJ Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch Clin Exp Ophthalmol 2000; 238:752–759.11045343, LafautBALeysAMSnyersBRasquinFDe LaeyJJ Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch Clin Exp Ophthalmol 2000; 238:752–759.11045343
A. Koh, T. Lai, Kanji Takahashi, T. Wong, Lee‐Jen Chen, Paisan Ruamviboonsuk, Colin Tan, C. Feller, P. Margaron, T. Lim, W. Lee (2017)
Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical TrialJAMA Ophthalmology, 135
P. Cackett, I. Yeo, C. Cheung, E. Vithana, Doric Wong, W. Tay, E. Tai, T. Aung, T. Wong (2011)
Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons.Ophthalmology, 118 5
(KawamuraAYuzawaMMoriRHaruyamaMTanakaK Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types. Acta Ophthalmol 2013; 91:e474–e481.23848133)
KawamuraAYuzawaMMoriRHaruyamaMTanakaK Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types. Acta Ophthalmol 2013; 91:e474–e481.23848133KawamuraAYuzawaMMoriRHaruyamaMTanakaK Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types. Acta Ophthalmol 2013; 91:e474–e481.23848133, KawamuraAYuzawaMMoriRHaruyamaMTanakaK Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types. Acta Ophthalmol 2013; 91:e474–e481.23848133
A. Koh, W. Lee, Lee‐Jen Chen, Shih-Jen Chen, Y. Hashad, Hakyoung Kim, T. Lai, S. Pilz, Paisan Ruamviboonsuk, E. Tokaji, A. Weisberger, T. Lim (2012)
EVEREST STUDY: Efficacy and Safety of Verteporfin Photodynamic Therapy in Combination with Ranibizumab or Alone Versus Ranibizumab Monotherapy in Patients with Symptomatic Macular Polypoidal Choroidal VasculopathyRetina, 32
F. Wen, Chang-Wen Chen, De-zheng Wu, Haitao Li (2004)
Polypoidal choroidal vasculopathy in elderly Chinese patientsGraefe's Archive for Clinical and Experimental Ophthalmology, 242
Yan Liu, F. Wen, Shi-zhou Huang, G. Luo, Hong Yan, Zu-hua Sun, De-zheng Wu (2007)
Subtype lesions of neovascular age-related macular degeneration in Chinese patientsGraefe's Archive for Clinical and Experimental Ophthalmology, 245
(Scassellati-SforzoliniBMariottiCBryanRYannuzziLAGiulianiMGiovanniniA Polypoidal choroidal vasculopathy in Italy. Retina 2001; 21:121–125.11321137)
Scassellati-SforzoliniBMariottiCBryanRYannuzziLAGiulianiMGiovanniniA Polypoidal choroidal vasculopathy in Italy. Retina 2001; 21:121–125.11321137Scassellati-SforzoliniBMariottiCBryanRYannuzziLAGiulianiMGiovanniniA Polypoidal choroidal vasculopathy in Italy. Retina 2001; 21:121–125.11321137, Scassellati-SforzoliniBMariottiCBryanRYannuzziLAGiulianiMGiovanniniA Polypoidal choroidal vasculopathy in Italy. Retina 2001; 21:121–125.11321137
F. Gomi, M. Sawa, K. Mitarai, M. Tsujikawa, Y. Tano (2007)
Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiographyGraefe's Archive for Clinical and Experimental Ophthalmology, 245
C. Cheung, Y. Yanagi, M. Akiba, A. Tan, R. Mathur, C. Chan, I. Yeo, T. Wong (2019)
IMPROVED DETECTION AND DIAGNOSIS OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING A COMBINATION OF OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.Retina
(Ohji M. Two different treat-and-extend dosing regimens of intravitreal aflibercept in Japanese patients with wet age-related macular degeneration: 96 week results of the ALTAIR study. Presented at: Euretina; Sept. 20-23, 2018; Vienna.)
Ohji M. Two different treat-and-extend dosing regimens of intravitreal aflibercept in Japanese patients with wet age-related macular degeneration: 96 week results of the ALTAIR study. Presented at: Euretina; Sept. 20-23, 2018; Vienna.Ohji M. Two different treat-and-extend dosing regimens of intravitreal aflibercept in Japanese patients with wet age-related macular degeneration: 96 week results of the ALTAIR study. Presented at: Euretina; Sept. 20-23, 2018; Vienna., Ohji M. Two different treat-and-extend dosing regimens of intravitreal aflibercept in Japanese patients with wet age-related macular degeneration: 96 week results of the ALTAIR study. Presented at: Euretina; Sept. 20-23, 2018; Vienna.
(KimKSLeeWK Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2011; 55:370–377.21647565)
KimKSLeeWK Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2011; 55:370–377.21647565KimKSLeeWK Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2011; 55:370–377.21647565, KimKSLeeWK Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2011; 55:370–377.21647565
S. Kuroiwa, H. Tateiwa, T. Hisatomi, T. Ishibashi, N. Yoshimura (2004)
Pathological features of surgically excised polypoidal choroidal vasculopathy membranesClinical & Experimental Ophthalmology, 32
(ZhangXLiMWenF Different impact of high-density lipoprotein-related genetic variants on polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population. Exp Eye Res 2013; 108:16–22.23274582)
ZhangXLiMWenF Different impact of high-density lipoprotein-related genetic variants on polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population. Exp Eye Res 2013; 108:16–22.23274582ZhangXLiMWenF Different impact of high-density lipoprotein-related genetic variants on polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population. Exp Eye Res 2013; 108:16–22.23274582, ZhangXLiMWenF Different impact of high-density lipoprotein-related genetic variants on polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population. Exp Eye Res 2013; 108:16–22.23274582
A. Ciardella, Irene Donsoff, L. Yannuzzi (2002)
Polypoidal choroidal vasculopathy.Ophthalmology clinics of North America, 15 4
V. Chaikitmongkol, Preeyanuch Khunsongkiet, D. Patikulsila, M. Ratanasukon, Nawat Watanachai, Chaisiri Jumroendararasame, C. Mayerle, Ian Han, Connie Chen, Pawara Winaikosol, Chutikarn Dejkriengkraikul, J. Choovuthayakorn, P. Kunavisarut, N. Bressler (2018)
Color Fundus Photography, Optical Coherence Tomography, and Fluorescein Angiography in Diagnosing Polypoidal Choroidal Vasculopathy.American journal of ophthalmology, 192
Yi Zhang, Jing Yao, Xiao-hua Wang, Lin Zhao, Li-jun Wang, Jianming Wang, Ai-yi Zhou (2016)
[Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy].Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 37 2
(CackettPYeoICheungCM Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons. Ophthalmology 2011; 118:846–852.21146223)
CackettPYeoICheungCM Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons. Ophthalmology 2011; 118:846–852.21146223CackettPYeoICheungCM Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons. Ophthalmology 2011; 118:846–852.21146223, CackettPYeoICheungCM Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons. Ophthalmology 2011; 118:846–852.21146223
(HoCPSLaiTYY Current management strategy of polypoidal choroidal vasculopathy. Indian J Ophthalmol 2018; 66:1727–1735.30451173)
HoCPSLaiTYY Current management strategy of polypoidal choroidal vasculopathy. Indian J Ophthalmol 2018; 66:1727–1735.30451173HoCPSLaiTYY Current management strategy of polypoidal choroidal vasculopathy. Indian J Ophthalmol 2018; 66:1727–1735.30451173, HoCPSLaiTYY Current management strategy of polypoidal choroidal vasculopathy. Indian J Ophthalmol 2018; 66:1727–1735.30451173
(ZhangYYaoJWangXH [Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy]. Nan Fang Yi Ke Da Xue Xue Bao 2016; 37:165–171.28219858)
ZhangYYaoJWangXH [Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy]. Nan Fang Yi Ke Da Xue Xue Bao 2016; 37:165–171.28219858ZhangYYaoJWangXH [Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy]. Nan Fang Yi Ke Da Xue Xue Bao 2016; 37:165–171.28219858, ZhangYYaoJWangXH [Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy]. Nan Fang Yi Ke Da Xue Xue Bao 2016; 37:165–171.28219858
(ChangYCChengCK Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy. Retina 2019; doi: 10.1097/IAE.0000000000002583.[Epub ahead of print].)
ChangYCChengCK Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy. Retina 2019; doi: 10.1097/IAE.0000000000002583.[Epub ahead of print].ChangYCChengCK Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy. Retina 2019; doi: 10.1097/IAE.0000000000002583.[Epub ahead of print]., ChangYCChengCK Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy. Retina 2019; doi: 10.1097/IAE.0000000000002583.[Epub ahead of print].
(GomiFSawaMMitaraiKTsujikawaMTanoY Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2007; 245:1421–1427.17347808)
GomiFSawaMMitaraiKTsujikawaMTanoY Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2007; 245:1421–1427.17347808GomiFSawaMMitaraiKTsujikawaMTanoY Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2007; 245:1421–1427.17347808, GomiFSawaMMitaraiKTsujikawaMTanoY Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2007; 245:1421–1427.17347808
(TsujikawaAOjimaYYamashiroK Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy. Am J Ophthalmol 2011; 151:961-972.21457926)
TsujikawaAOjimaYYamashiroK Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy. Am J Ophthalmol 2011; 151:961-972.21457926TsujikawaAOjimaYYamashiroK Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy. Am J Ophthalmol 2011; 151:961-972.21457926, TsujikawaAOjimaYYamashiroK Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy. Am J Ophthalmol 2011; 151:961-972.21457926
T. Wong, Y. Ogura, W. Lee, T. Iida, Shih-Jen Chen, P. Mitchell, Chui Cheung, Zhongqi Zhang, S. Leal, T. Ishibashi (2019)
Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: 2-Year Results of the PLANET Study.American journal of ophthalmology
Christine Ho, T. Lai (2018)
Current management strategy of polypoidal choroidal vasculopathyIndian Journal of Ophthalmology, 66
(2005)
[Criteria for diagnosis of polypoidal choroidal vasculopathy].Nippon Ganka Gakkai zasshi, 109 7
(LadasIDRouvasAAMoschosMMSynodinosEEKaragiannisDAKoutsandreaCN Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population. Eye (Lond) 2004; 18:455–459.15131673)
LadasIDRouvasAAMoschosMMSynodinosEEKaragiannisDAKoutsandreaCN Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population. Eye (Lond) 2004; 18:455–459.15131673LadasIDRouvasAAMoschosMMSynodinosEEKaragiannisDAKoutsandreaCN Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population. Eye (Lond) 2004; 18:455–459.15131673, LadasIDRouvasAAMoschosMMSynodinosEEKaragiannisDAKoutsandreaCN Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population. Eye (Lond) 2004; 18:455–459.15131673
K. Graham, U. Chakravarthy, R. Hogg, K. Muldrew, I. Young, F. Kee (2017)
IDENTIFYING FEATURES OF EARLY AND LATE AGE-RELATED MACULAR DEGENERATION: A Comparison of Multicolor Versus Traditional Color Fundus PhotographyRetina, 38
(YannuzziLACiardellaASpaideRFRabbMFreundKBOrlockDA The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 1997; 115:478–485.9109756)
YannuzziLACiardellaASpaideRFRabbMFreundKBOrlockDA The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 1997; 115:478–485.9109756YannuzziLACiardellaASpaideRFRabbMFreundKBOrlockDA The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 1997; 115:478–485.9109756, YannuzziLACiardellaASpaideRFRabbMFreundKBOrlockDA The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 1997; 115:478–485.9109756
Colin Tan (2017)
The Role of Optical Coherence Tomography Angiography in Polypoidal Choroidal Vasculopathy.JAMA ophthalmology, 135 12
K. Sho, Kanji Takahashi, Haruhiko Yamada, M. Wada, Y. Nagai, T. Otsuji, M. Nishikawa, Y. Mitsuma, Y. Yamazaki, M. Matsumura, M. Uyama (2003)
Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics.Archives of ophthalmology, 121 10
(YuzawaMMoriRKawamuraA The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol 2005; 89:602–607.15834093)
YuzawaMMoriRKawamuraA The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol 2005; 89:602–607.15834093YuzawaMMoriRKawamuraA The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol 2005; 89:602–607.15834093, YuzawaMMoriRKawamuraA The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol 2005; 89:602–607.15834093
(ShoKTakahashiKYamadaH Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003; 121:1392–1396.14557174)
ShoKTakahashiKYamadaH Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003; 121:1392–1396.14557174ShoKTakahashiKYamadaH Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003; 121:1392–1396.14557174, ShoKTakahashiKYamadaH Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003; 121:1392–1396.14557174
(PauleikhoffDLöffertDSpitalG Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002; 240:533–538.12136282)
PauleikhoffDLöffertDSpitalG Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002; 240:533–538.12136282PauleikhoffDLöffertDSpitalG Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002; 240:533–538.12136282, PauleikhoffDLöffertDSpitalG Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002; 240:533–538.12136282
(YangJZhangCWangEChenYYuW Utility of a public-available artificial intelligence in diagnosis of polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2020; 258:17–21.31686211)
YangJZhangCWangEChenYYuW Utility of a public-available artificial intelligence in diagnosis of polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2020; 258:17–21.31686211YangJZhangCWangEChenYYuW Utility of a public-available artificial intelligence in diagnosis of polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2020; 258:17–21.31686211, YangJZhangCWangEChenYYuW Utility of a public-available artificial intelligence in diagnosis of polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2020; 258:17–21.31686211
K. Mori, Kuniko Horie-Inoue, P. Gehlbach, H. Takita, Sho Kabasawa, I. Kawasaki, T. Ohkubo, Susumu Kurihara, H. Iizuka, Y. Miyashita, S. Katayamá, T. Awata, S. Yoneya, S. Inoue (2010)
Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population.Ophthalmology, 117 5
I. Maruko, T. Iida, M. Saito, D. Nagayama, Kuniharu Saito (2007)
Clinical characteristics of exudative age-related macular degeneration in Japanese patients.American journal of ophthalmology, 144 1
T. Lai, W. Chan, D. Liu, F. Luk, D. Lam (2008)
Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathyBritish Journal of Ophthalmology, 92
(ZhangXWenFZuoCLiMChenHWuK Association of genetic variation on chromosome 9p21 with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2011; 52:8063–8067.21896860)
ZhangXWenFZuoCLiMChenHWuK Association of genetic variation on chromosome 9p21 with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2011; 52:8063–8067.21896860ZhangXWenFZuoCLiMChenHWuK Association of genetic variation on chromosome 9p21 with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2011; 52:8063–8067.21896860, ZhangXWenFZuoCLiMChenHWuK Association of genetic variation on chromosome 9p21 with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2011; 52:8063–8067.21896860
De-Kuang Hwang, Chang‐Sue Yang, F. Lee, W. Hsu (2007)
Idiopathic polypoidal choroidal vasculopathy.Journal of the Chinese Medical Association : JCMA, 70 2
Colin Tan, Dominic Ting, L. Lim (2019)
Multicolor Fundus Imaging of Polypoidal Choroidal Vasculopathy.Ophthalmology. Retina, 3 5
(LaudeACackettPDVithanaEN Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res 2010; 29:19–29.19854291)
LaudeACackettPDVithanaEN Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res 2010; 29:19–29.19854291LaudeACackettPDVithanaEN Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res 2010; 29:19–29.19854291, LaudeACackettPDVithanaEN Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res 2010; 29:19–29.19854291
(ChangYCWuWC Polypoidal choroidal vasculopathy in Taiwanese patients. Ophthalmic Surg Lasers Imaging 2009; 40:576–581.19928723)
ChangYCWuWC Polypoidal choroidal vasculopathy in Taiwanese patients. Ophthalmic Surg Lasers Imaging 2009; 40:576–581.19928723ChangYCWuWC Polypoidal choroidal vasculopathy in Taiwanese patients. Ophthalmic Surg Lasers Imaging 2009; 40:576–581.19928723, ChangYCWuWC Polypoidal choroidal vasculopathy in Taiwanese patients. Ophthalmic Surg Lasers Imaging 2009; 40:576–581.19928723
(BoQYanQShenM Appearance of polypoidal lesions in patients with polypoidal choroidal vasculopathy using swept-source optical coherence tomographic angiography. JAMA Ophthalmol 2019; 137:642–650.30998817)
BoQYanQShenM Appearance of polypoidal lesions in patients with polypoidal choroidal vasculopathy using swept-source optical coherence tomographic angiography. JAMA Ophthalmol 2019; 137:642–650.30998817BoQYanQShenM Appearance of polypoidal lesions in patients with polypoidal choroidal vasculopathy using swept-source optical coherence tomographic angiography. JAMA Ophthalmol 2019; 137:642–650.30998817, BoQYanQShenM Appearance of polypoidal lesions in patients with polypoidal choroidal vasculopathy using swept-source optical coherence tomographic angiography. JAMA Ophthalmol 2019; 137:642–650.30998817
Zongyi Zhan, Limei Sun, C. Jin, Yu Yang, A. Hu, Miao Tang, Zhirong Wang, Xiaoyan Ding (2019)
Comparison between non-visualized polyps and visualized polyps on optical coherence tomography angiography in polypoidal choroidal vasculopathyGraefe's Archive for Clinical and Experimental Ophthalmology, 257
(PangCEFreundKB Pachychoroid neovasculopathy. Retina 2015; 35:1–9.25158945)
PangCEFreundKB Pachychoroid neovasculopathy. Retina 2015; 35:1–9.25158945PangCEFreundKB Pachychoroid neovasculopathy. Retina 2015; 35:1–9.25158945, PangCEFreundKB Pachychoroid neovasculopathy. Retina 2015; 35:1–9.25158945
(ChaikitmongkolVKongJKhunsongkietP Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy. JAMA Ophthalmol 2019; 137:661–667.30973593)
ChaikitmongkolVKongJKhunsongkietP Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy. JAMA Ophthalmol 2019; 137:661–667.30973593ChaikitmongkolVKongJKhunsongkietP Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy. JAMA Ophthalmol 2019; 137:661–667.30973593, ChaikitmongkolVKongJKhunsongkietP Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy. JAMA Ophthalmol 2019; 137:661–667.30973593
(CheungCMGLaiTYYRuamviboonsukP Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 2018; 125:708–724.29331556)
CheungCMGLaiTYYRuamviboonsukP Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 2018; 125:708–724.29331556CheungCMGLaiTYYRuamviboonsukP Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 2018; 125:708–724.29331556, CheungCMGLaiTYYRuamviboonsukP Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 2018; 125:708–724.29331556
L. Yannuzzi, J. Sorenson, R. Spaide, B. Lipson (1990)
IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)Retina, 10
(YangJYuanMWangEXiaSChenY Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy. BMC Ophthalmol 2019; 19:229.31733642)
YangJYuanMWangEXiaSChenY Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy. BMC Ophthalmol 2019; 19:229.31733642YangJYuanMWangEXiaSChenY Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy. BMC Ophthalmol 2019; 19:229.31733642, YangJYuanMWangEXiaSChenY Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy. BMC Ophthalmol 2019; 19:229.31733642
H. Fukuyama, Hisashi Iwami, Takashi Araki, H. Ishikawa, N. Ikeda, F. Gomi (2018)
Indocyanine Green Dye Filling Time for Polypoidal Lesions in Polypoidal Choroidal Vasculopathy Affects the Visibility of the Lesions on OCT Angiography.Ophthalmology. Retina, 2 8
(WongCWYanagiYLeeWK Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 2016; 53:107–139.27094371)
WongCWYanagiYLeeWK Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 2016; 53:107–139.27094371WongCWYanagiYLeeWK Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 2016; 53:107–139.27094371, WongCWYanagiYLeeWK Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 2016; 53:107–139.27094371
B. Lafaut, S. Aisenbrey, Caroline Broecke, K. Bartz-Schmidt, K. Heimann (2000)
POLYPOIDAL CHOROIDAL VASCULOPATHY PATTERN IN AGE‐RELATED MACULAR DEGENERATION: A Clinicopathologic CorrelationRetina, 20
M. Yuzawa, R. Mori, A. Kawamura (2005)
The origins of polypoidal choroidal vasculopathyBritish Journal of Ophthalmology, 89
(InoueMBalaratnasingamCFreundKB Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypodal choroidal neovascularization. Retina 2015; 35:2265–2274.26405770)
InoueMBalaratnasingamCFreundKB Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypodal choroidal neovascularization. Retina 2015; 35:2265–2274.26405770InoueMBalaratnasingamCFreundKB Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypodal choroidal neovascularization. Retina 2015; 35:2265–2274.26405770, InoueMBalaratnasingamCFreundKB Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypodal choroidal neovascularization. Retina 2015; 35:2265–2274.26405770
(ChaikitmongkolVKhunsongkietPPatikulsilaD Color fundus photography, optical coherence tomography, and fluorescein angiography in diagnosing polypoidal choroidal vasculopathy. Am J Ophthalmol 2018; 192:77–83.29753852)
ChaikitmongkolVKhunsongkietPPatikulsilaD Color fundus photography, optical coherence tomography, and fluorescein angiography in diagnosing polypoidal choroidal vasculopathy. Am J Ophthalmol 2018; 192:77–83.29753852ChaikitmongkolVKhunsongkietPPatikulsilaD Color fundus photography, optical coherence tomography, and fluorescein angiography in diagnosing polypoidal choroidal vasculopathy. Am J Ophthalmol 2018; 192:77–83.29753852, ChaikitmongkolVKhunsongkietPPatikulsilaD Color fundus photography, optical coherence tomography, and fluorescein angiography in diagnosing polypoidal choroidal vasculopathy. Am J Ophthalmol 2018; 192:77–83.29753852
Yang Li, Q. You, W. Wei, Jie Xu, C. Chen, Y. Wang, Liang Xu, J. Jonas (2014)
Polypoidal choroidal vasculopathy in adult chinese: the Beijing Eye Study.Ophthalmology, 121 11
(GrahamKWChakravarthyUHoggREMuldrewKAYoungISKeeF Identifying features of early and late age-relate4d macular degeneration: a comparison of multicolor versus traditional color fundus photography. Retina 2018; 38:1751–1758.28834946)
GrahamKWChakravarthyUHoggREMuldrewKAYoungISKeeF Identifying features of early and late age-relate4d macular degeneration: a comparison of multicolor versus traditional color fundus photography. Retina 2018; 38:1751–1758.28834946GrahamKWChakravarthyUHoggREMuldrewKAYoungISKeeF Identifying features of early and late age-relate4d macular degeneration: a comparison of multicolor versus traditional color fundus photography. Retina 2018; 38:1751–1758.28834946, GrahamKWChakravarthyUHoggREMuldrewKAYoungISKeeF Identifying features of early and late age-relate4d macular degeneration: a comparison of multicolor versus traditional color fundus photography. Retina 2018; 38:1751–1758.28834946
(YannuzziLAWongDWSforzoliniBS Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 1999; 117:1503–1510.10565519)
YannuzziLAWongDWSforzoliniBS Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 1999; 117:1503–1510.10565519YannuzziLAWongDWSforzoliniBS Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 1999; 117:1503–1510.10565519, YannuzziLAWongDWSforzoliniBS Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 1999; 117:1503–1510.10565519
(WenFChenCWuDLiH Polypoidal choroidal vasculopathy in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol 2004; 242:625–629.15257461)
WenFChenCWuDLiH Polypoidal choroidal vasculopathy in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol 2004; 242:625–629.15257461WenFChenCWuDLiH Polypoidal choroidal vasculopathy in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol 2004; 242:625–629.15257461, WenFChenCWuDLiH Polypoidal choroidal vasculopathy in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol 2004; 242:625–629.15257461
C. Cheung, Xiang Li, Ching-Yu Cheng, Yingfeng Zheng, P. Mitchell, Jie-Jin Wang, T. Wong (2014)
Prevalence, racial variations, and risk factors of age-related macular degeneration in Singaporean Chinese, Indians, and Malays.Ophthalmology, 121 8
W. Lee, T. Iida, Y. Ogura, Shih-Jen Chen, T. Wong, P. Mitchell, G. Cheung, Zhongqi Zhang, S. Leal, T. Ishibashi (2018)
Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical TrialJAMA Ophthalmology, 136
Ran Liu, Jia-qing Li, Zijing Li, Shanshan Yu, Yu Yang, Hong Yan, J. Zeng, Shibo Tang, Xiaoyan Ding (2016)
DISTINGUISHING POLYPOIDAL CHOROIDAL VASCULOPATHY FROM TYPICAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION BASED ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHYRetina, 36
(KohALaiTYTakahashiK Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial. JAMA Ophthalmol 2017; 135:1206–1213.28983556)
KohALaiTYTakahashiK Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial. JAMA Ophthalmol 2017; 135:1206–1213.28983556KohALaiTYTakahashiK Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial. JAMA Ophthalmol 2017; 135:1206–1213.28983556, KohALaiTYTakahashiK Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial. JAMA Ophthalmol 2017; 135:1206–1213.28983556
(HongTTanAGMitchellPWangJJ A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration. Surv Ophthalmol 2011; 56:184–194.21420705)
HongTTanAGMitchellPWangJJ A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration. Surv Ophthalmol 2011; 56:184–194.21420705HongTTanAGMitchellPWangJJ A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration. Surv Ophthalmol 2011; 56:184–194.21420705, HongTTanAGMitchellPWangJJ A review and meta-analysis of the association between C-reactive protein and age-related macular degeneration. Surv Ophthalmol 2011; 56:184–194.21420705
Yoichi Sakurada, T. Kubota, M. Imasawa, F. Mabuchi, Yasushi Tateno, N. Tanabe, H. Iijima (2011)
Role of complement factor H I62V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy.Ophthalmology, 118 7
X. Liang, L. Chen, T. Ng, J. Tuo, Ji-Liang Gao, P. Tam, T. Lai, C. Chan, C. Pang (2014)
FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathyEye, 28
H. Nakashizuka, M. Mitsumata, S. Okisaka, H. Shimada, A. Kawamura, R. Mori, M. Yuzawa (2008)
Clinicopathologic findings in polypoidal choroidal vasculopathy.Investigative ophthalmology & visual science, 49 11
(UetaTObataRInoueY Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 2009; 116:2400–2406.19815291)
UetaTObataRInoueY Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 2009; 116:2400–2406.19815291UetaTObataRInoueY Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 2009; 116:2400–2406.19815291, UetaTObataRInoueY Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 2009; 116:2400–2406.19815291
(ChangYSKimJHKimJWLeeTGKimCG Optical coherence tomography-based diagnosis of polypoidal choroidal vasculopathy in Korean Patients. Korean J Ophthalmol 2016; 30:198–205.27247519)
ChangYSKimJHKimJWLeeTGKimCG Optical coherence tomography-based diagnosis of polypoidal choroidal vasculopathy in Korean Patients. Korean J Ophthalmol 2016; 30:198–205.27247519ChangYSKimJHKimJWLeeTGKimCG Optical coherence tomography-based diagnosis of polypoidal choroidal vasculopathy in Korean Patients. Korean J Ophthalmol 2016; 30:198–205.27247519, ChangYSKimJHKimJWLeeTGKimCG Optical coherence tomography-based diagnosis of polypoidal choroidal vasculopathy in Korean Patients. Korean J Ophthalmol 2016; 30:198–205.27247519
H. Chen, Ke Liu, L. Chen, P. Hou, Weiqi Chen, C. Pang (2012)
Genetic associations in polypoidal choroidal vasculopathy: A systematic review and meta-analysisMolecular Vision, 18
MD Yannuzzi, MD Wong, MD Sforzolini, MD Goldbaum, Kong, MD Tang, MD Spaide, MD Freund, MD Slakter, MD Guyer, MD Sorenson, MD Fisher, MD Maberley, Cra Orlock (1999)
Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration.Archives of ophthalmology, 117 11
G. Coscas, M. Lupidi, F. Coscas, F. Benjelloun, J. Zerbib, A. Dirani, O. Semoun, E. Souied (2015)
Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration.Investigative ophthalmology & visual science, 56 5
Kohta Fujiwara, Miho Yasuda, J. Hata, Y. Oshima, Sawako Hashimoto, T. Yoshitomi, Y. Kiyohara, T. Ishibashi, T. Ninomiya, K. Sonoda (2018)
Prevalence and Risk Factors for Polypoidal Choroidal Vasculopathy in a General Japanese Population: The Hisayama StudySeminars in Ophthalmology, 33
G. Coscas, K. Yamashiro, F. Coscas, U. Benedetto, A. Tsujikawa, M. Miyake, Chui Cheung, T. Wong, N. Yoshimura (2014)
Comparison of exudative age-related macular degeneration subtypes in Japanese and French Patients: multicenter diagnosis with multimodal imaging.American journal of ophthalmology, 158 2
P. Dugel, A. Koh, Y. Ogura, G. Jaffe, U. Schmidt-Erfurth, David Brown, A. Gomes, J. Warburton, A. Weichselberger, F. Holz (2019)
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.Ophthalmology
Jingyuan Yang, Mingzhen Yuan, E. Wang, Song Xia, You-xin Chen (2019)
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathyBMC Ophthalmology, 19
(LiuYWenFHuangS Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol 2007; 245:1441–1445.17406882)
LiuYWenFHuangS Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol 2007; 245:1441–1445.17406882LiuYWenFHuangS Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol 2007; 245:1441–1445.17406882, LiuYWenFHuangS Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol 2007; 245:1441–1445.17406882
L. Yannuzzi, A. Ciardella, R. Spaide, M. Rabb, K. Freund, D. Orlock (1997)
The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.Archives of ophthalmology, 115 4
(MaLBrelenMETsujikawaM Identification of ANGPT2 as a new gene for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in the Chinese and Japanese populations. Invest Ophthalmol Vis Sci 2017; 58:1076–1083.28192798)
MaLBrelenMETsujikawaM Identification of ANGPT2 as a new gene for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in the Chinese and Japanese populations. Invest Ophthalmol Vis Sci 2017; 58:1076–1083.28192798MaLBrelenMETsujikawaM Identification of ANGPT2 as a new gene for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in the Chinese and Japanese populations. Invest Ophthalmol Vis Sci 2017; 58:1076–1083.28192798, MaLBrelenMETsujikawaM Identification of ANGPT2 as a new gene for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in the Chinese and Japanese populations. Invest Ophthalmol Vis Sci 2017; 58:1076–1083.28192798
Kyu Kim, W. Lee (2011)
Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathyJapanese Journal of Ophthalmology, 55
(De SalvoGVaz-PereiraSKeanePATufailALiewG Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2014; 158: 1228-1238.e1.)
De SalvoGVaz-PereiraSKeanePATufailALiewG Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2014; 158: 1228-1238.e1.De SalvoGVaz-PereiraSKeanePATufailALiewG Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2014; 158: 1228-1238.e1., De SalvoGVaz-PereiraSKeanePATufailALiewG Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2014; 158: 1228-1238.e1.
(TanCSNgoWKLimLWLimTH A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol 2014; 98:1528–1533.24997181)
TanCSNgoWKLimLWLimTH A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol 2014; 98:1528–1533.24997181TanCSNgoWKLimLWLimTH A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol 2014; 98:1528–1533.24997181, TanCSNgoWKLimLWLimTH A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol 2014; 98:1528–1533.24997181
(MengQHuangLSunY Effect of high-density lipoprotein metabolic pathway gene variations and risk factors on neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in China. PloS One 2015; 10:e0143924.26624898)
MengQHuangLSunY Effect of high-density lipoprotein metabolic pathway gene variations and risk factors on neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in China. PloS One 2015; 10:e0143924.26624898MengQHuangLSunY Effect of high-density lipoprotein metabolic pathway gene variations and risk factors on neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in China. PloS One 2015; 10:e0143924.26624898, MengQHuangLSunY Effect of high-density lipoprotein metabolic pathway gene variations and risk factors on neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in China. PloS One 2015; 10:e0143924.26624898
(WongTYOguraYLeeWK Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: two-year results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study. Am J Ophthalmol 2019; 204:80–89.30849345)
WongTYOguraYLeeWK Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: two-year results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study. Am J Ophthalmol 2019; 204:80–89.30849345WongTYOguraYLeeWK Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: two-year results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study. Am J Ophthalmol 2019; 204:80–89.30849345, WongTYOguraYLeeWK Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: two-year results of the Aflibercept in Polypoidal Choroidal Vasculopathy Study. Am J Ophthalmol 2019; 204:80–89.30849345
(OkuboASameshimaMUemuraAKandaSOhbaN Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol 2002; 86:1093–1098.12234885)
OkuboASameshimaMUemuraAKandaSOhbaN Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol 2002; 86:1093–1098.12234885OkuboASameshimaMUemuraAKandaSOhbaN Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol 2002; 86:1093–1098.12234885, OkuboASameshimaMUemuraAKandaSOhbaN Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol 2002; 86:1093–1098.12234885
W. Lee, Jiwon Baek, K. Dansingani, Jae Lee, K. Freund
CHOROIDAL MORPHOLOGY IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY AND NORMAL OR SUBNORMAL SUBFOVEAL CHOROIDAL THICKNESS
(GomiFOshimaYMoriR Initial versus delayed photodynamic therapy in combination with ranibizumab for treatment of polypoidal choroidal vasculopathy: The Fujisan Study. Retina 2015; 35:1569–1576.25830698)
GomiFOshimaYMoriR Initial versus delayed photodynamic therapy in combination with ranibizumab for treatment of polypoidal choroidal vasculopathy: The Fujisan Study. Retina 2015; 35:1569–1576.25830698GomiFOshimaYMoriR Initial versus delayed photodynamic therapy in combination with ranibizumab for treatment of polypoidal choroidal vasculopathy: The Fujisan Study. Retina 2015; 35:1569–1576.25830698, GomiFOshimaYMoriR Initial versus delayed photodynamic therapy in combination with ranibizumab for treatment of polypoidal choroidal vasculopathy: The Fujisan Study. Retina 2015; 35:1569–1576.25830698
A. Kawamura, M. Yuzawa, R. Mori, M. Haruyama, Koji Tanaka (2013)
Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two typesActa Ophthalmologica, 91
A. Okubo, M. Sameshima, A. Uemura, S. Kanda, N. Ohba (2002)
Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural studyBritish Journal of Ophthalmology, 86
Y. Chang, Jae Kim, Jong Kim, T. Lee, C. Kim (2016)
Optical Coherence Tomography-based Diagnosis of Polypoidal Choroidal Vasculopathy in Korean PatientsKorean Journal of Ophthalmology : KJO, 30
(ChenHLiuKChenLJHouPChenWPangCP Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis. Mol Vis 2012; 18:816–829.22509112)
ChenHLiuKChenLJHouPChenWPangCP Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis. Mol Vis 2012; 18:816–829.22509112ChenHLiuKChenLJHouPChenWPangCP Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis. Mol Vis 2012; 18:816–829.22509112, ChenHLiuKChenLJHouPChenWPangCP Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis. Mol Vis 2012; 18:816–829.22509112
B. Scassellati-Sforzolini, C. Mariotti, R. Bryan, L. Yannuzzi, M. Giuliani, A. Giovannini (2001)
POLYPOIDAL CHOROIDAL VASCULOPATHY IN ITALYRetina, 21
(QuJChengYLiX Efficacy of intravitreal injection of conbercept in polypoidal choroidal vasculopathy: subgroup analysis of the Aurora Study. Retina 2016; 36:926–937.26595362)
QuJChengYLiX Efficacy of intravitreal injection of conbercept in polypoidal choroidal vasculopathy: subgroup analysis of the Aurora Study. Retina 2016; 36:926–937.26595362QuJChengYLiX Efficacy of intravitreal injection of conbercept in polypoidal choroidal vasculopathy: subgroup analysis of the Aurora Study. Retina 2016; 36:926–937.26595362, QuJChengYLiX Efficacy of intravitreal injection of conbercept in polypoidal choroidal vasculopathy: subgroup analysis of the Aurora Study. Retina 2016; 36:926–937.26595362
(MoriKHorie-InoueKGehlbachPL Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population. Ophthalmology 2010; 117:928–938.20132989)
MoriKHorie-InoueKGehlbachPL Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population. Ophthalmology 2010; 117:928–938.20132989MoriKHorie-InoueKGehlbachPL Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population. Ophthalmology 2010; 117:928–938.20132989, MoriKHorie-InoueKGehlbachPL Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population. Ophthalmology 2010; 117:928–938.20132989
(AlshahraniSTAl ShamsiHNKahtaniESGhaziNG Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern. Clin Ophthalmol 2014; 8:1689–1695.25214762)
AlshahraniSTAl ShamsiHNKahtaniESGhaziNG Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern. Clin Ophthalmol 2014; 8:1689–1695.25214762AlshahraniSTAl ShamsiHNKahtaniESGhaziNG Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern. Clin Ophthalmol 2014; 8:1689–1695.25214762, AlshahraniSTAl ShamsiHNKahtaniESGhaziNG Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern. Clin Ophthalmol 2014; 8:1689–1695.25214762
R. Stern, Z. Zakov, H. Zegarra, F. Gutman (1985)
Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women.American journal of ophthalmology, 100 4
(KuroiwaSTateiwaHHisatomiTIshibashiTYoshimuraN Pathological features of surgically excised polypoidal choroidal vasculopathy membranes. Clin Exp Ophthalmol 2004; 32:297–302.15180844)
KuroiwaSTateiwaHHisatomiTIshibashiTYoshimuraN Pathological features of surgically excised polypoidal choroidal vasculopathy membranes. Clin Exp Ophthalmol 2004; 32:297–302.15180844KuroiwaSTateiwaHHisatomiTIshibashiTYoshimuraN Pathological features of surgically excised polypoidal choroidal vasculopathy membranes. Clin Exp Ophthalmol 2004; 32:297–302.15180844, KuroiwaSTateiwaHHisatomiTIshibashiTYoshimuraN Pathological features of surgically excised polypoidal choroidal vasculopathy membranes. Clin Exp Ophthalmol 2004; 32:297–302.15180844
C. Cheung, T. Lai, Paisan Ruamviboonsuk, Shih-Jen Chen, You-xin Chen, K. Freund, F. Gomi, A. Koh, W. Lee, T. Wong (2018)
Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management.Ophthalmology, 125 5
Jingyuan Yang, Chenxi Zhang, E. Wang, You-xin Chen, Weihong Yu (2019)
Utility of a public-available artificial intelligence in diagnosis of polypoidal choroidal vasculopathyGraefe's Archive for Clinical and Experimental Ophthalmology, 258
(MarukoIIidaTSaitoMNagayamaDSaitoK Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007; 144:15–22.17509509)
MarukoIIidaTSaitoMNagayamaDSaitoK Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007; 144:15–22.17509509MarukoIIidaTSaitoMNagayamaDSaitoK Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007; 144:15–22.17509509, MarukoIIidaTSaitoMNagayamaDSaitoK Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007; 144:15–22.17509509
Min Wang, Yao Zhou, Simon Gao, W. Liu, Yongheng Huang, David Huang, Yali Jia (2016)
Evaluating Polypoidal Choroidal Vasculopathy With Optical Coherence Tomography AngiographyInvestigative Ophthalmology & Visual Science, 57
Yun-Chia Chang, Cheng-Kuo Cheng (2020)
DIFFERENCE BETWEEN PACHYCHOROID AND NONPACHYCHOROID POLYPOIDAL CHOROIDAL VASCULOPATHY AND THEIR RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.Retina
(TanakaKNakayamaTMoriR Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2011; 52:7441–7444.21896867)
TanakaKNakayamaTMoriR Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2011; 52:7441–7444.21896867TanakaKNakayamaTMoriR Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2011; 52:7441–7444.21896867, TanakaKNakayamaTMoriR Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2011; 52:7441–7444.21896867
(CheungCMGYanagiYAkibaM Improved detection and diagnosis of polypoidal choroidal vasculopathy using a combination of optical coherence tomography and optical coherence tomography angiography. Retina 2019; 39:1655–1663.29927796)
CheungCMGYanagiYAkibaM Improved detection and diagnosis of polypoidal choroidal vasculopathy using a combination of optical coherence tomography and optical coherence tomography angiography. Retina 2019; 39:1655–1663.29927796CheungCMGYanagiYAkibaM Improved detection and diagnosis of polypoidal choroidal vasculopathy using a combination of optical coherence tomography and optical coherence tomography angiography. Retina 2019; 39:1655–1663.29927796, CheungCMGYanagiYAkibaM Improved detection and diagnosis of polypoidal choroidal vasculopathy using a combination of optical coherence tomography and optical coherence tomography angiography. Retina 2019; 39:1655–1663.29927796
V. Chaikitmongkol, Jun Kong, Preeyanuch Khunsongkiet, D. Patikulsila, Mira Sachdeva, Pimploy Chavengsaksongkram, Chutikarn Dejkriengkraikul, Pawara Winaikosol, J. Choovuthayakorn, Nawat Watanachai, P. Kunavisarut, T. Ingviya, N. Bressler (2019)
Sensitivity and Specificity of Potential Diagnostic Features Detected Using Fundus Photography, Optical Coherence Tomography, and Fluorescein Angiography for Polypoidal Choroidal Vasculopathy.JAMA ophthalmology
(WangMZhouYGaoSS Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography. Invest Ophthalmol Vis Sci 2016; 57:OCT526-OCT532.27472276)
WangMZhouYGaoSS Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography. Invest Ophthalmol Vis Sci 2016; 57:OCT526-OCT532.27472276WangMZhouYGaoSS Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography. Invest Ophthalmol Vis Sci 2016; 57:OCT526-OCT532.27472276, WangMZhouYGaoSS Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography. Invest Ophthalmol Vis Sci 2016; 57:OCT526-OCT532.27472276
(LiYYouQSWeiWB Polypoidal choroidal vasculopathy in adult chinese: the Beijing Eye Study. Ophthalmology 2014; 121:2290–2291.25109927)
LiYYouQSWeiWB Polypoidal choroidal vasculopathy in adult chinese: the Beijing Eye Study. Ophthalmology 2014; 121:2290–2291.25109927LiYYouQSWeiWB Polypoidal choroidal vasculopathy in adult chinese: the Beijing Eye Study. Ophthalmology 2014; 121:2290–2291.25109927, LiYYouQSWeiWB Polypoidal choroidal vasculopathy in adult chinese: the Beijing Eye Study. Ophthalmology 2014; 121:2290–2291.25109927
(ThomasJWGrossniklausHELambertHMAabergTML’HernaultN Ultrastructural features of surgically excised idiopathic subfoveal neovascular membranes. Retina 1993; 13:93–98.8337507)
ThomasJWGrossniklausHELambertHMAabergTML’HernaultN Ultrastructural features of surgically excised idiopathic subfoveal neovascular membranes. Retina 1993; 13:93–98.8337507ThomasJWGrossniklausHELambertHMAabergTML’HernaultN Ultrastructural features of surgically excised idiopathic subfoveal neovascular membranes. Retina 1993; 13:93–98.8337507, ThomasJWGrossniklausHELambertHMAabergTML’HernaultN Ultrastructural features of surgically excised idiopathic subfoveal neovascular membranes. Retina 1993; 13:93–98.8337507
Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/01/2020 CE: M.S.; APJO/APJO-2020-41; Total nos of Pages: 9; APJO-2020-41 REVIEW ARTICLE Latest Developments in Polypoidal Choroidal Vasculopathy: Epidemiology, Etiology, Diagnosis, and Treatment Voraporn Chaikitmongkol, MD , Chui Ming Gemmy Cheung, FRCOphthyz, Hideki Koizumi, MD, PhD§, Vishal Govindahar, MD{, Jay Chhablani, MDjj, and Timothy Y.Y. Lai, MD, FRCOphth yy overview of the current literature in the epidemiology, pathogen- Abstract: Polypoidal choroidal vasculopathy (PCV) is a condition char- esis, genetics of PCV, and recent research findings in the diagno- acterized by multiple, recurrent, serosanguineous pigment epithelial sis and treatment of PCV. detachments, and neurosensory retinal detachments due to abnormal aneurysmal neovascular lesions. It is generally considered as a variant of neovascular age-related macular degeneration, but there are some EPIDEMIOLOGY OF PCV differences between the clinical presentation, natural history, and treat- There is growing evidence of increasing prevalence of age- ment response between patients with PCV and typical neovascular age- related macular degeneration (AMD) worldwide. In Asian popu- related macular degeneration patients. Over the past decade, new research lation-based studies, the prevalence of early AMD and late AMD and technological advancements have greatly improved our understand- has been reported to range from 1.4% to 37.9%
The Asia-Pacific Journal of Ophthalmology – Wolters Kluwer Health
Published: May 1, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.